Subcutaneous mosunetuzumab plus polatuzumab vedotin boosts responses in relapsed large B-cell lymphoma, helping community oncology care.
|Articles|February 1, 1996
The American Journal of Managed Care
- February 1996
- Volume 2
- Issue 2
Estimated Costs of Treating Stress Urinary Incontinence in Elderly Women According to the AHCPR Clinical Practice Guidelines
Advertisement
Articles in this issue
over 30 years ago
Adapting Pharmacy Services to the Needs of Managed Careover 30 years ago
Advanced Practice Nurses and Success of Organized Delivery Systemsover 30 years ago
Ethical Issues in Managed Careover 30 years ago
The Economics of Compliance in Managed Healthcare SettingsAdvertisement
Related to this article
Using baseline samples from 177 patients in the VISION/HO141 trial, researchers built a functional prognostic model for CLL that outperformed the CLL-IPI.
Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.
The Franklin County death is under state review as Pennsylvania's measles outbreak passed 1100 cases and 219 hospitalizations.
Among 4378 Spanish registry patients, dyshidrotic eczema was less tied to occupation than other hand eczema.
New non-CF bronchiectasis in Medicare is tied to high health care use and $8998 PPPM FFS spending; prevalence is highest in older women.
Understanding the Potential Risks of Prescription Drug Affordability Boards and Upper Payment Limits
NPC researchers examined questions about how these policies could affect patients, pharmacies, and providers.
The expanded indication rests on evidence extrapolated from carcinoma in situ, a new FDA approach to closely related forms of bladder cancer.
Advertisement
Advertisement
Trending on AJMC
1
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
2
FDA Approves First Treatment for BCG-Unresponsive Bladder Cancer
3
MedHaul Closes Care Gaps With Single Stop for Getting Patients to Appointments
4
Iberdomide Regimen Cuts RRMM Progression Risk by 51%, Trial Finds
5